A medtech lead generation agency should help medical device manufacturers, OEMs and distributors reach the right accounts, qualify buying intent and connect marketing activity to sales opportunities. The best provider for your 2027 plan is the one that can explain who it will reach, what counts as qualified and how sales will use each lead.
A badge scan, an engineer’s research request and a hospital procurement conversation should not be treated as equivalent wins. Compare agencies by the sales motion you need to support—not by a single promised lead volume.
What should a MedTech agency actually deliver?
Ask for a connected operating plan: target accounts and roles, approved messaging, channel execution, explicit qualification rules, CRM handoffs and opportunity reporting. Each deliverable should have an owner and an acceptance standard. A proposal that stops at traffic, downloads or booked meetings leaves the commercial question unanswered.
Which providers belong on a practical shortlist?
Use the providers below as different starting points for a proposal request, not as an ordered ranking. Percepture publishes this guide and is included as a provider. This comparison concerns stated positioning and proposal fit; it does not rank medical-device campaign outcomes.
Provider positioning and the evidence to request
| Provider | Public starting point | When to explore a proposal | What to request |
|---|---|---|---|
| Percepture — publisher of this guide | A dedicated life-sciences industry page and an omnichannel marketing service page. | You want to evaluate an integrated plan across discovery, campaigns and sales handoffs. | A device-specific audience map, qualification definitions, review responsibilities and a channel-to-CRM measurement plan. |
| Icovy | Its agency description discusses founders, product leaders and marketers, with positioning around launches, brands and demand systems. | Your brief needs launch positioning and demand development considered together. | Relevant device-category work and a clear explanation of where launch activity becomes qualified commercial demand. |
| Stratabeat | Its medical-device marketing page positions the offering around organic growth and qualified leads. | You want to explore an organic-led acquisition plan. | A search-intent map, conversion-path examples and an explanation of how organic inquiries become accepted opportunities. |
Send each agency the same business problem. For example: “We need procurement-ready conversations for this product line in these territories,” rather than “We need more leads.” Ask each proposal to state its assumptions about product readiness, sales capacity, content approvals and existing account coverage.
That makes the comparison useful. One agency may propose positioning work before acquisition; another may emphasize capturing existing search demand. Compare the reasoning and deliverables against your situation instead of treating different scopes as interchangeable retainers.
Percepture’s lead generation service page is a relevant starting point for a proposal conversation. Keep the evaluation device-specific: general life-sciences experience should not substitute for evidence about your audience, product category and selling process.
Define the buyer before defining the lead
“MedTech” is too broad to serve as a targeting brief. Separate the organization you want to reach, the person you want to engage and the action that would justify a sales conversation.
An R&D engineer requesting technical information should receive a different qualification path from a distributor asking about territory coverage. Likewise, a clinician’s interest should not automatically be recorded as a hospital purchasing decision.
Targeting by account, role and commercial intent
| Audience | Clarify before targeting | Useful next action | Qualification mistake to avoid |
|---|---|---|---|
| Device manufacturer or OEM | Product line, application, geography and whether the inquiry concerns components, services or a finished device. | A scoped technical or commercial discussion. | Treating every employee at a target manufacturer as a buyer. |
| R&D engineer | Technical requirements, development stage and the evaluation question. | A specification review, sample discussion or feasibility conversation appropriate to the offering. | Equating early research with an active request for quotation. |
| Healthcare professional | Professional role, relevant setting and the purpose of the inquiry. | An appropriate product-information discussion. | Assuming professional interest establishes purchasing authority. |
| Hospital buying committee | Roles to involve, decision criteria, procurement path and the next agreed milestone. | A discussion that includes the stakeholders needed for that milestone. | Counting several contacts at one hospital as several independent opportunities. |
| Distributor | Territory, portfolio fit, customer coverage and commercial requirements. | A channel-fit conversation with documented follow-up. | Recording a partnership inquiry as an end-customer sale. |
Build the account record around the buying situation, then attach relevant contacts. For a committee-based opportunity, record who is engaged, whose input is still needed and what decision comes next. Do not reward a campaign for multiplying contact records while leaving the account no closer to a decision.
A useful customer journey plan should connect those next actions to content and follow-up. An engineer may need a technical resource before a meeting; a procurement contact may need a commercial discussion. The agency’s job is to make those paths explicit, not route everyone through the same download form.
What counts as a qualified MedTech lead?
Agree on definitions with sales before approving campaigns. Use the following as a working model, then adapt it to your product and CRM. These are proposed operating definitions, not industry-wide standards.
A lead is a contact or inquiry. A marketing-qualified lead meets your agreed marketing criteria. A sales-accepted lead has been accepted for follow-up. A sales-qualified opportunity has a documented buying situation and next step under your sales team’s rules. None of these labels should be assigned solely because someone opened an email or attended a booth.
Measure progression, not just acquisition
| Stage | Working acceptance rule | Metric to inspect | Diagnostic question |
|---|---|---|---|
| Inquiry | A usable contact record with source and inquiry context. | Valid inquiries and invalid-record reasons. | Are we attracting relevant people or merely collecting submissions? |
| Marketing-qualified lead | Agreed account fit, role fit and a meaningful intent signal. | MQL-to-sales-acceptance rate. | Does sales agree that the qualification rule identifies useful demand? |
| Sales-accepted lead | Sales accepts ownership and records the next action. | Acceptance rate and time to first follow-up. | Is the handoff failing because of fit, missing context or capacity? |
| Qualified opportunity | Sales documents the buying situation and an agreed next step. | Accepted-lead-to-opportunity rate and opportunity value. | Which sources produce conversations that advance? |
| Closed business | The CRM records the commercial outcome. | Opportunity-to-win rate, sales-cycle duration and acquisition economics. | Did the program create commercially useful demand? |
For each conversion rate, specify the numerator, denominator and reporting cohort. Sales acceptance rate could mean accepted leads divided by leads handed to sales; it should not quietly change to accepted leads divided by all website submissions midway through the engagement.
Also separate new opportunities from existing opportunities influenced by a campaign. Ask the agency to preserve duplicates, disqualification reasons and stage-change history in its analysis rather than reporting only the attractive totals.
Your attribution and analytics plan should state how campaign sources connect to CRM records and where attribution remains uncertain. A sourced opportunity and an influenced opportunity are different reporting categories; neither should be counted twice in a combined total.
Choose channels around the next buying action
Do not start with a channel bundle. Start with the question your buyer needs answered and the action you want to support.
Search and AI discovery
Ask for a search plan that distinguishes technical research from commercial evaluation. Application pages, specification resources and supplier-selection content should have different conversion paths when they serve different intentions.
For AI discovery, distinguish three observations: the brand is mentioned, the company’s own domain is cited, or the provider is explicitly recommended. Require the prompt, engine, date and captured answer when an agency reports those observations. A brand mention is not evidence of a referral, meeting or sale.
If generative engine optimization services are included, evaluate their scope separately from lead acquisition. Ask what content will change, how visibility will be observed and how any commercial contribution will be measured. Do not accept answer visibility as a replacement for CRM outcomes.
Paid media
Give paid campaigns a qualification hypothesis: which account types and roles should respond, what the landing page should communicate and what information sales needs after conversion.
Before launch, have the agency and your qualified reviewers assess the proposed ads and destinations against the applicable Google Ads healthcare and medicines policies. Treat platform-policy review and product-claims review as distinct responsibilities. Neither a campaign plan nor an agency’s general healthcare experience establishes that a particular execution is appropriate.
Conferences, events and follow-up
For conference marketing, define the pre-event account list, the on-site conversation criteria and the post-event handoff before committing to acquisition targets. Classify a badge scan as a contact capture; require additional context before calling it qualified demand.
Write down why the person engaged, which product or application they discussed and the follow-up they agreed to. A useful event report should show what happened after the booth, including accepted conversations and opportunities—not just the number of scanned badges.
Keep promotional conference activity separate from any accredited continuing medical education activity. Have the relevant organizers and qualified reviewers determine what participation and messaging are appropriate.
An omnichannel marketing plan should explain how these channels connect. The practical test is whether the next interaction reflects what the buyer already asked, rather than restarting the conversation with a generic sales message.
Build content review into the scope
Ask the agency to document a review path before it drafts product claims. Name the people responsible for technical accuracy, clinical statements where relevant, legal or regulatory assessment and final publication.
Start with an approved source pack for the specific product and market. The FDA medical devices resources are a useful reference point for a U.S.-focused review, but product-specific decisions belong with your qualified team.
For each asset, record the intended audience, market, supported statements, source material and approval status. Apply that process to ads, landing pages, nurture emails, event materials and agency-produced sales content—not just the main website.
Require version control and a named owner for revisions. If a product statement changes, the team should be able to identify where it appears and update the affected material. If an agency proposes AI-assisted drafting, ask how its output passes through the same review process.
The agency should manage the workflow without presenting itself as a substitute for your clinical, technical or legal decision-makers.
Eight questions to ask before signing
The strongest proposal conversation is specific enough that vague answers become obvious.
- Which accounts and roles will you target first? Ask for inclusion and exclusion criteria, geography and the reasoning behind the initial segment.
- What exactly makes a lead qualified? Require a written rule that sales can accept or challenge, including how research-stage contacts and partner inquiries are handled.
- What relevant work can you substantiate? Ask for the product context, audience, period, channels and outcome definitions. Separate device-specific evidence from analogous life-sciences experience.
- How will you support a buying committee? Ask how contacts attach to accounts and how the campaign identifies the next stakeholder or decision milestone.
- Who owns product-claims and content review? Require named responsibilities, source requirements and revision procedures—not a general assurance about compliance.
- What happens after a lead arrives? Ask about routing, duplicate handling, required context, follow-up ownership and rejected-lead feedback.
- Which costs sit outside the agency fee? Clarify media spend, production, software, data, event costs and the ownership of accounts and deliverables.
- How will we decide whether to continue or change course? Agree on reporting cohorts, leading indicators, opportunity measures and a review point that fits your sales process.
A medtech lead generation agency should be able to show how its answers connect. Targeting determines the content; content shapes the inquiry; qualification determines the handoff; the handoff makes the reporting meaningful. If those pieces belong to separate workstreams, ask who is accountable for the complete path.
Compare evidence against your sales motion
Use published case studies to examine audience fit, campaign scope and outcome definitions. Keep analogous sector experience separate from medical-device evidence, and ask how the proposed approach would change for your business.
MedTech agency selection questions
Is medical-device marketing the same as patient lead generation?
Not for this buying brief. This guide concerns B2B demand from manufacturers, OEMs, distributors and healthcare purchasing stakeholders. A patient-acquisition brief has a different audience and conversion goal. Ask the agency to keep those scopes separate.
Should we buy leads or engage an agency?
Evaluate a purchased contact list separately from a program that creates and qualifies demand. If considering purchased leads, ask about sourcing, permitted use, account fit, duplicates and the evidence of intent. Do not treat a contact record as a qualified opportunity.
How long should an agency pilot run?
Set the evaluation period around the work required and your sales process, rather than a universal deadline. Agree on early deliverables such as targeting, approved assets and CRM handoffs, then evaluate lead acceptance and opportunity progression as the relevant cohorts mature.
About Bob Generale
Bob Generale is President of Percepture and the author of this guide.
